
Acerca de
Program
9.30-9.35 Welcome & introduction - H.L.A. Janssen
Liver tumors - Chair D. Sprengers
9.35-9.50 How to optimize HCC surveillance in chronic HBV infection – M.J. Sonneveld
9.50-10.15 TIPS before advanced therapies for HCC – D. Thabut
10.15-10.20 Case – A. van Eldere
10.20-10.35 Advanced treatment for HCC: Immunotherapy – F.A.L.M. Eskens
10.35-10.50 Advanced treatment for HCC: Radioembolization – M.G.E.H. Lam
10.50-11.00 Interactive table discussion
11.00-11.30 Break
Liver Transplantation - Chair S. Darwish Murad
11.30-11.45 Referral for liver transplantation with a low MELD score? – C.M. den Hoed
11.45-12.05 Working around the MELD: Living-related donation liver transplantation – R.J. Porte
12.05-12.30 How to optimize a liver graft using machine perfusion – V.E. de Meijer
12.30-12.40 Interactive table discussion
12.40-13.40 Lunch
State of the Art - Chair R. Maan
13.40-14.10 Acute kidney injury & fluid/salt balances in liver disease – E.J. Hoorn
​
State of the Art - Chair H.L.A. Janssen
14.10-14.15 Solko W. Schalm Award Ceremony
14.15-14.45 HBV/HDV: present and future – H. Wedemeyer
NASH - Chair R.J. de Knegt
14.45-15.00 NASH & Fibrosis screening in the population based setting – W.P. Brouwer
15.00-15.20 Holistic approach for the treatment of patients with NASH – E.F.C. van Rossum
15.20-15.30 Interactive table discussion
State of the Art - Chair A.J.P. van der Meer
15.30-16.00 Difficult to treat AIH – Treatment roadmap, off-label therapies and response criteria – C. Schramm
16.00-16.10 Closing remarks – H.L.A. Janssen
16.10 Drinks
​